Onkos Surgical® and 3D Systems Team to Advance Personalized Surgical Oncology Solutions -
  1. Surgical
  2. Onkos Surgical® and 3D Systems Team to Advance Personalized Surgical Oncology Solutions

Onkos Surgical® and 3D Systems Team to Advance Personalized Surgical Oncology Solutions

Onkos Surgical

Onkos Surgical, Inc. signed a 4-year agreement with 3D Systems to advance the delivery of personalized surgical solutions and help improve patient outcomes. The agreement gives Onkos Surgical priority access to 3D Systems’ VSP® (Virtual Surgical Planning) Orthopedic product line for surgical planning, as well as 3D printed anatomical models. In addition, the companies will collaborate on next-generation 510(k) clearances for 3D printed implants and instruments for tumor reconstruction.

Through this partnership, the companies aim to advance the delivery of personalized surgical solutions to help improve outcomes for patients with tumors and lesions occurring in the pelvis and long bones (i.e., the large bones found in the arms and legs) associated with musculoskeletal cancers. The combination of VSP and 3D printing lets surgeons preoperatively plan a surgical procedure, as well as design surgical tools and implants for each patient’s unique case.

With VSP technology, surgeons initiate the process, bringing their clinical knowledge and desired surgical plan to an online web meeting with a 3D Systems biomedical engineer to simulate and plan the surgical procedure. The outcome is a digital plan that is transferred to the operating room via accurate 3D printed patient-specific models, guides and templates.

Patrick Treacy, co-founder and chief executive officer, Onkos Surgical says 3D Systems “was an early stage investor in Onkos, and understands the criticality of our connection to the customer, the unique challenges these surgeons and patients face and the tremendous opportunity we have to make a difference for these patients while building a high value and scalable business.”

According to the NIH – National Cancer Institute (cancer.gov), there were 3,260 new primary bone cancer cases reported in 2017. In addition to chemotherapy and radiation, two common surgical options for musculoskeletal cancer patients are amputation and limb salvage. Through limb salvage, the surgeon removes the cancer and some healthy tissue with the goal of leaving the limb largely intact. The section of bone that was removed can be replaced either with a bone graft from the patient or another person, or with an internal prosthesis (i.e., implants) made of metal and other materials.

Articles By This Author